EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development

Thomas Vallet iD, Marco Vignuzzi

Viruses · 14.04.2025 · 17 (4) · 566

DOI: 10.3390/v17040566 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 14.04.2025. Verfasst von Thomas Vallet und 1 weiteren Autor:innen. Beteiligte Einrichtung: A*STAR Infectious Diseases Labs (A*IDL), Agency for Science, Technology and Research (A*STAR), Singapore 138634, Singapore. Hauptthemen laut MEDLINE: Vaccine Development, Alphavirus, RNA, Viral. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Self-amplifying RNA is synthetic nucleic acid engineered to replicate within cells without generating viral particles. Derived from alphavirus genomes, saRNA retains the non-structural elements essential for replication while replacing the structural elements with an antigen of interest. By enabling efficient intracellular amplification, saRNA offers a promising alternative to conventional mRNA vaccines, enhancing antigen expression while requiring lower doses. However, this advantage comes with challenges. In this review, we highlight the key limitations of saRNA technology and explore potential strategies to overcome them. By identifying these challenges, we aim to provide insights that can guide the future design of saRNA-based therapeutics, extending their potential beyond vaccine applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccine DevelopmentAlphavirusRNA, ViralHumansAnimalsGenome, ViralVirus Replication

Stichwörter der Autor:innen

VEEValphavirusdeliverylimitationsmRNAsaRNAsafetyvaccine

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • A*STAR Infectious Diseases Labs (A*IDL), Agency for Science, Technology and Research (A*STAR), Singapore 138634, Singapore.
  • Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 118420, Singapore.

ORCID-Profile: Thomas Vallet

Zitieren

APA

Vallet, T., & Vignuzzi, M. (2025). Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development. Viruses, 17(4), 566. https://doi.org/10.3390/v17040566

Vancouver

Vallet T, Vignuzzi M. Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development. Viruses. 2025;17(4):566. doi:10.3390/v17040566

BibTeX
@article{Vallet2025,
  author = {Vallet, Thomas and Vignuzzi, Marco},
  title = {Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development},
  journal = {Viruses},
  year = {2025},
  volume = {17},
  number = {4},
  pages = {566},
  doi = {10.3390/v17040566}
}
Kostenlos starten →